Oppenheimer & CO Inc Danaher Corp Transaction History

Oppenheimer & CO Inc

  • $6.18 Billion
  • Q2 2024

A detailed history of Oppenheimer & CO Inc transactions in Danaher Corp stock. As of the latest transaction made, Oppenheimer & CO Inc holds 25,004 shares of DHR stock, worth $6.07 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
25,004
Previous 24,047 3.98%
Holding current value
$6.07 Million
Previous $6.01 Million 4.03%
% of portfolio
0.1%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$235.51 - $267.98 $225,383 - $256,456
957 Added 3.98%
25,004 $6.25 Million
Q1 2024

May 06, 2024
BUY
$224.58 - $256.19 $208,185 - $237,488
927 Added 4.01%
24,047 $6.01 Million
Q4 2023

Feb 13, 2024
SELL
$185.1 - $233.13 $186,395 - $234,761
-1,007 Reduced 4.17%
23,120 $5.35 Million
Q3 2023

Nov 07, 2023
SELL
$233.08 - $265.59 $280,628 - $319,770
-1,204 Reduced 4.75%
24,127 $5.99 Million
Q2 2023

Aug 02, 2023
BUY
$224.99 - $256.14 $571,024 - $650,083
2,538 Added 11.13%
25,331 $6.08 Million
Q1 2023

May 10, 2023
SELL
$239.75 - $277.0 $941,018 - $1.09 Million
-3,925 Reduced 14.69%
22,793 $5.74 Million
Q4 2022

Feb 07, 2023
BUY
$241.42 - $282.29 $919,810 - $1.08 Million
3,810 Added 16.63%
26,718 $7.09 Million
Q3 2022

Nov 14, 2022
SELL
$247.06 - $1507.4 $62,753 - $382,879
-254 Reduced 1.1%
22,908 $5.92 Million
Q2 2022

Aug 08, 2022
BUY
$237.11 - $299.66 $1.25 Million - $1.58 Million
5,266 Added 29.43%
23,162 $5.87 Million
Q1 2022

May 12, 2022
BUY
$257.27 - $315.76 $330,849 - $406,067
1,286 Added 7.74%
17,896 $5.25 Million
Q4 2021

Feb 02, 2022
SELL
$292.08 - $329.01 $5,841 - $6,580
-20 Reduced 0.12%
16,610 $5.47 Million
Q3 2021

Nov 12, 2021
BUY
$272.21 - $332.43 $92,006 - $112,361
338 Added 2.07%
16,630 $5.06 Million
Q2 2021

Aug 03, 2021
SELL
$225.08 - $271.69 $743,889 - $897,935
-3,305 Reduced 16.86%
16,292 $4.37 Million
Q1 2021

May 10, 2021
BUY
$212.38 - $245.9 $47,573 - $55,081
224 Added 1.16%
19,597 $4.41 Million
Q4 2020

Feb 11, 2021
SELL
$212.5 - $245.46 $32,300 - $37,309
-152 Reduced 0.78%
19,373 $4.3 Million
Q3 2020

Nov 13, 2020
SELL
$177.16 - $215.33 $821,845 - $998,915
-4,639 Reduced 19.2%
19,525 $4.2 Million
Q2 2020

Aug 11, 2020
SELL
$128.7 - $176.83 $16,988 - $23,341
-132 Reduced 0.54%
24,164 $4.27 Million
Q1 2020

May 08, 2020
BUY
$121.39 - $169.05 $296,798 - $413,327
2,445 Added 11.19%
24,296 $3.36 Million
Q4 2019

Feb 07, 2020
BUY
$133.47 - $153.48 $11,211 - $12,892
84 Added 0.39%
21,851 $3.35 Million
Q3 2019

Oct 31, 2019
BUY
$135.4 - $146.47 $227,065 - $245,630
1,677 Added 8.35%
21,767 $3.14 Million
Q2 2019

Aug 09, 2019
SELL
$124.88 - $143.73 $266,993 - $307,294
-2,138 Reduced 9.62%
20,090 $2.87 Million
Q1 2019

Apr 24, 2019
SELL
$97.62 - $132.29 $122,805 - $166,420
-1,258 Reduced 5.36%
22,228 $2.94 Million
Q4 2018

Jan 29, 2019
SELL
$94.85 - $109.54 $139,714 - $161,352
-1,473 Reduced 5.9%
23,486 $2.42 Million
Q3 2018

Oct 26, 2018
SELL
$98.13 - $108.9 $237,278 - $263,320
-2,418 Reduced 8.83%
24,959 $2.71 Million
Q2 2018

Aug 10, 2018
BUY
$96.1 - $103.24 $350,572 - $376,619
3,648 Added 15.37%
27,377 $2.7 Million
Q1 2018

May 01, 2018
SELL
$92.16 - $103.8 $186,624 - $210,195
-2,025 Reduced 7.86%
23,729 $2.32 Million
Q4 2017

Feb 07, 2018
BUY
$85.26 - $94.62 $23,446 - $26,020
275 Added 1.08%
25,754 $2.39 Million
Q3 2017

Nov 09, 2017
BUY
$79.29 - $88.45 $2.02 Million - $2.25 Million
25,479
25,479 $2.19 Million

Others Institutions Holding DHR

# of Institutions
2,432
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.11M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email